Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)

Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)

US Patent 6764820 · Granted Jul 20, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Computational filtering of methylated sequence data for predictive modeling2024
Methods of protecting a solid organ transplant tissue with angiopoietin-2 antibo2019
Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis2018
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy2016
Connexin mutation detection for lymphatic variation and disease2016
Connexin mutation detection for lymphatic variation and disease2016
Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis2015
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy2015
Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth facto2014
Pharmaceutical compositions comprising a VEGF-D polypeptide2014
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof,2014
Method of enhancing the acceptance and/or healing of a skin graft2013